Post by
QuantumBull9 on Nov 25, 2024 11:38am
Breakouts in Focus: $SRRK and $MYNZ
$SRRK surged today on SMA treatment breakthroughs, clearing key levels near $32-32.50 with rising MACD. Meanwhile, $MYNZ is gaining traction as its non-invasive cancer tests align with growing healthcare needs, holding solid support at 0.21. Both are riding strong sector momentum.